Becton Dickinson & Co. (NYSE:BDX) said today that it closed the acquisition of Caesarea Medical Electronics for an undisclosed amount, 2 years after its CareFusion subsidiary bought a stake in the infusion pump maker.
In March 2014, CareFusion paid $100 million for 40% of Caesarea Medical, which makes a range of infusion and syringe pumps and accessories for both home and clinic settings.
“Our relationship with BD has been very successful over the past 2 years, and this is the next logical step to elevate our infusion technologies,” CME founder Swi Barak said in prepared remarks. “This transaction will create new opportunities for our people and our technology that we wouldn’t have been able to achieve alone.”
“The integration of CME’s technology into BD will strengthen our strategy of reinventing medication management across the health care continuum,” added worldwide infusion solutions GM Mike Garrison. “The acquisition of CME advances our mission to provide efficient end-to-end IV safety solutions across a broad journey of care.”
Steve MacMillan took over as CEO of Hologic in 2013, drawing on his experience at medtech titans like Stryker and Johnson & Johnson. Since then, Hologic has grown into a $3 billion business.
At DeviceTalks Boston, MacMillan will provide exclusive insights into the Massachusetts-based company and its evolving definition of women's healthcare. You don't want to miss it!
Use code WOMENSHEALTH to save an additional 10%.